Parse

Parse indexes AI recommendations so brands know where they stand.

Products

  • Brands
  • Markets
  • Integrations
  • Work with us
  • Pricing
  • MCP

Resources

  • Research
  • Methodology
  • Blog

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Work with usPricing
Sign inCheck your brand
  1. Brands
  2. Genesis Therapeutics
BrandsGenesis Therapeutics

How AI describes Genesis Therapeutics

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

Genesis Therapeutics logoGenesis Therapeuticsgenesis.ml

Genesis Molecular AI is an AI platform for small molecule drug discovery that combines foundation models with physics-based simulations. Its GEMS operating system enables researchers to design molecules and run drug discovery workflows using advanced AI models.

Parse Score

51.1
Strength16
Reach37
Authority31

Work at Genesis Therapeutics?

Claim this profile for the full report: every prompt where Genesis Therapeutics appears, who is gaining, and what AI says about you. Claiming is free and unlocks your brand’s ambient view. Monitoring a market is the paid layer on top.

Verified with a work email.

Track this weekly.

Monitor Genesis Therapeutics

Sources

consainsights.com shapes more of what AI says about Genesis Therapeutics than any other source, at 25% of its citations.

genesis.ml · bioai-agents.com · businesswire.com · deepmirror.ai

AI questions where Genesis Therapeutics appears

  • Excerpts where Genesis Therapeutics appeared in the AI's answer

    Google AI Mode · excerpt
    Genesis Therapeutics (GEMS) : Focuses heavily on physics-informed AI foundation models
    Google AI Mode · excerpt
    Genesis Therapeutics: Focuses on molecular simulation models with quantum-level accuracy

  • Excerpts where Genesis Therapeutics appeared in the AI's answer

    Google AI Mode · excerpt
    Genesis Therapeutics: Focuses on AI-driven molecular generation to create small molecule drugs.

Always know where you stand in AI

Start monitoring Genesis Therapeutics